OBJECTIVES: Pericardial adipose tissue (PAT) is associated with coronary artery plaque accumulation and the incidence of coronary heart disease. We evaluated the possible incremental prognostic value of PAT for future cardiovascular events. METHODS: 145 patients (94 males, age 60 ± 10 years) with stable coronary artery disease underwent coronary artery calcification (CAC) scanning in a multislice CT scanner, and the volume of pericardial fat was measured. Mean observation time was 5.4 years. RESULTS: 34 patients experienced a severe cardiac event. They had a significantly higher CAC score (1,708 ± 2,269 vs. 538 ± 1,150, p < 0.01), and the CAC score was highly correlated with the relative risk of a future cardiac event: 2.4 (1.8-3.7; p = 0.01) for scores >400, 3.5 (1.9-5.4; p = 0.007) for scores >800 and 5.9 (3.7-7.8; p = 0.005) for scores >1,600. When additionally a PAT volume >200 cm(3) was determined, there was a significant increase in the event rate and relative risk. We calculated a relative risk of 2.9 (1.9-4.2; p = 0.01) for scores >400, 4.0 (2.1-5.0; p = 0.006) for scores >800 and 7.1 (4.1-10.2; p = 0.005) for scores >1,600. CONCLUSIONS: The additional determination of PAT increases the predictive power of CAC for future cardiovascular events. PAT might therefore be used as a further parameter for risk stratification.
OBJECTIVES: Pericardial adipose tissue (PAT) is associated with coronary artery plaque accumulation and the incidence of coronary heart disease. We evaluated the possible incremental prognostic value of PAT for future cardiovascular events. METHODS: 145 patients (94 males, age 60 ± 10 years) with stable coronary artery disease underwent coronary artery calcification (CAC) scanning in a multislice CT scanner, and the volume of pericardial fat was measured. Mean observation time was 5.4 years. RESULTS: 34 patients experienced a severe cardiac event. They had a significantly higher CAC score (1,708 ± 2,269 vs. 538 ± 1,150, p < 0.01), and the CAC score was highly correlated with the relative risk of a future cardiac event: 2.4 (1.8-3.7; p = 0.01) for scores >400, 3.5 (1.9-5.4; p = 0.007) for scores >800 and 5.9 (3.7-7.8; p = 0.005) for scores >1,600. When additionally a PAT volume >200 cm(3) was determined, there was a significant increase in the event rate and relative risk. We calculated a relative risk of 2.9 (1.9-4.2; p = 0.01) for scores >400, 4.0 (2.1-5.0; p = 0.006) for scores >800 and 7.1 (4.1-10.2; p = 0.005) for scores >1,600. CONCLUSIONS: The additional determination of PAT increases the predictive power of CAC for future cardiovascular events. PAT might therefore be used as a further parameter for risk stratification.
Authors: Mingxia Yuan; Fang-Chi Hsu; Donald W Bowden; Jianzhao Xu; S Carrie Smith; Lynne E Wagenknecht; Mary E Comeau; Jasmin Divers; Thomas C Register; J Jeffrey Carr; Carl D Langefeld; Barry I Freedman Journal: Obesity (Silver Spring) Date: 2016-06-29 Impact factor: 5.002
Authors: Andrew H Talman; Peter J Psaltis; James D Cameron; Ian T Meredith; Sujith K Seneviratne; Dennis T L Wong Journal: Cardiovasc Diagn Ther Date: 2014-12
Authors: Holger Hetterich; Axel Rominger; Lisa Walter; Maximilian Habs; Sarah Volpers; Marcus Hacker; Maximilian F Reiser; Peter Bartenstein; Tobias Saam Journal: Int J Cardiovasc Imaging Date: 2015-04-22 Impact factor: 2.357
Authors: James V Spearman; Matthias Renker; U Joseph Schoepf; Aleksander W Krazinski; Teri L Herbert; Carlo N De Cecco; Paul J Nietert; Felix G Meinel Journal: Eur Radiol Date: 2015-04-30 Impact factor: 5.315
Authors: Martin Greif; Franz von Ziegler; Reza Wakili; Janine Tittus; Christoph Becker; Susanne Helbig; Ruediger P Laubender; Wolfgang Schwarz; Melvin D'Anastasi; Jan Schenzle; Alexander W Leber; Alexander Becker Journal: Clin Res Cardiol Date: 2013-04-13 Impact factor: 5.460
Authors: Ho Cheol Hong; Soon Young Hwang; Soyeon Park; Ja Young Ryu; Hae Yoon Choi; Hye Jin Yoo; Ji-A Seo; Sin Gon Kim; Nan Hee Kim; Sei Hyun Baik; Dong Seop Choi; Sungeun Kim; Kyung Mook Choi Journal: PLoS One Date: 2015-08-13 Impact factor: 3.240
Authors: Regitse H Christensen; Bernt Johan von Scholten; Christian S Hansen; Magnus T Jensen; Tina Vilsbøll; Peter Rossing; Peter G Jørgensen Journal: Cardiovasc Diabetol Date: 2019-08-30 Impact factor: 9.951